The first question is why in the case of SLE anti-MBP IgGs there are more major cleavage sites of sequences corresponding to X-OP21 and X-OP25 than those for MS abzymes in the case of intact MBP as substrate. This evidence concerns the gene MBP and systemic lupus erythematosus.